Top three stocks that saw heavy demand from buyers in the pre-opening session today
These three stocks were the top gainers on BSE in the pre-opening session today.
At the pre-opening bell, the frontline index S&P BSE Sensex opened in red with a loss of 179.62 points or 0.23 per cent. By 9.17 am, the index stood at 78,561.10 signifying a loss of 114.08 points or 0.15 per cent over its previous closing.
DSIJ offers a service 'Technical Advisory Services' with recommendations for best swing trading stocks based on research and analysis to help subscribers make healthy profits. If this interests you, then do download the service details pdf here
On the sectoral front, in the pre-opening session, metals dropped by 0.33 per cent, power zoomed by 0.11 and auto slipped by 0.15 per cent.
Meanwhile, KNR Constructions Ltd , Ashoka Buildcon Ltd and Suven Pharmaceuticals Ltd emerged as the Top Gainers of BSE in the pre-opening session today.
KNR Constructions Ltd an S&P BSE company, surged 10.43 per cent to trade at Rs 313.80 apiece. The company has announced its Quarterly Results for the second quarter ending September 30, 2024.
Ashoka Buildcon Ltd rallied 7.29 per cent to trade at Rs 241.45 apiece. The company has announced its quarterly results for the second quarter ending September 30, 2024.
Suven Pharmaceuticals Ltd an S&P BSE company, climbed 6.25 per cent to trade at Rs 1,279 apiece. The company has announced its quarterly results for the second quarter ending September 30, 2024. The company reported progress in its strategic initiatives, including a strong pipeline in Phase III, an increase in Request for Quotations (RFQs), and conversion of Spec-Chem/Ag-Chem business to SBU, setting the stage for future growth. Revenue for the quarter stood at Rs 258Cr., posting a growth of 12 per cent YoY, and gross margins witnessed a 473 bps expansion driven primarily by business mix and the consolidation of the recently acquired oligonucleotide business. Adjusted EBITDA was Rs 112 Cr. with EBITDA margins at 43.3 per cent
Disclaimer: The article is for informational purposes only and not investment advice.